The new whole blood CRA along with a dye-dilution proliferation assay were effective tools for monitoring gluten immunity in CD patients without needing a gluten food challenge to expand the pool of gluten-specific CD4+ T cells. The gene discussed is CD4; the disease is Cowden disease.